BPRL PRIVATE LIMITED | Herbal Division | Super speciality Division
Targeted therapy for Efficacy & Safety

Gefitinib

In NSCLC

First line therapy in locally advanced or metastatic NSCLC in Asian patients

Provide Superior efficacy in EGFR mutation positive patients

As second line therapy in locally advanced or metastatic NSCLC

As maintenance therapy after first line chemotherapy in patients affected by advanced NSCL

Also Recommeded in

Metastatic Breast Cancer

Head & Neck Cancer